Abstract:OBJECTIVE:To investigate the application potential of alginate-strontium (Sr) hydrogel as an injectable scaffold material in bone tissue engineering.METHODS:The alginate-Sr/-calcium (Ca) hydrogel beads were fabricated by adding 2.0 wt% alginate sodium to 0.2 mol/L SrCl2/CaCl2 solution dropwise. Microstructure, modulus of compression, swelling rate, and degradability of alginate-Sr/-Ca hydrogels were tested. Bone marrow mesenchymal stem cells (BMSCs) were isolated from femoral bones of rabbits by flushing of marrow cavity. BMSCs at passage 5 were seeded onto the alginate-Sr hydrogel (experimental group) and alginate-Ca hydrogel (control group), and the viability and proliferation of BMSCs in 2 alginate hydrogels were assessed. The osteogenic differentiation of cells embeded in 2 alginate hydrogels was evaluated by alkaline phosphate (ALP) activity, osteoblast specific gene [Osterix (OSX), collagen type I, and Runx2] expression level and calcium deposition by fluorescent quantitative RT-PCR and alizarin red staining, Von Kossa staining. The BMSCs which were embeded in alginate-Ca hydrogel and cultured with common growth medium were harvested as blank control group.RESULTS:The micromorphology of alginate-Sr hydrogel was similar to that of the alginate-Ca hydrogel, with homogeneous pore structure; the modulus of compression of alginate-Sr hydrogel and alginate-Ca hydrogel was (186.53 +/- 8.37) and (152.14 +/- 7.45) kPa respectively, showing significant difference (t=6.853, P=0.002); there was no significant difference (t=0.737, P=0.502) in swelling rate between alginate-Sr hydrogel (14.32% +/- 1.53%) and alginate-Ca hydrogel (15.25% +/- 1.64%). The degradabilities of 2 alginate hydrogels were good; the degradation rate of alginate-Sr hydrogel was significantly lower than that of alginate-Ca hydrogel on the 20th, 25th, and 30th days (P < 0.05). At 1-4 days, the morphology of cells on 2 alginate hydrogels was spherical and then the shape was spindle or stellate. When three-dimensional cultured for 21 days, the DNA content of BMSCs in experimental group [(4.38 +/- 0.24) g] was significantly higher than that in control group [(3.25 +/- 0.21) g] (t=8.108, P=0.001). On the 12th day after osteogenic differentiation, the ALP activity in experimental group was (15.28 +/- 1.26) U/L, which was significantly higher than that in control group [(12.07 +/- 1.12) U/L] (P < 0.05). Likewise, the mRNA expressions of OSX, collagen type I, and Runx2 in experimental group were significantly higher than those in control group (P < 0.05). On the 21th day after osteogenic differentiation, alizarin red staining and Von Kossa staining showed calcium deposition in 2 groups; the calcium nodules and phosphate deposition in experimental group were significantly higher than those in control group (P < 0.05).CONCLUSION:Alginate-Sr hydrogel has good physicochemical properties and can promote the proliferation and osteogenic differentiation of BMSCs, so it is an excellent injectable scaffold material for bone tissue engineering.

Preparation of in situ forming and injectable alginate/mesoporous Sr-containing calcium silicate composite cement for bone repair

A Novel Injectable Magnesium/Calcium Sulfate Hemihydrate Composite Cement for Bone Regeneration

Calcium Sulfate Cement Combined With Silica-Based Mesoporous Material For Bone Regeneration: In Vitro And In Vivo Study

IN VITRO STUDY ON INJECTABLE ALGINATE-STRONTIUM HYDROGEL FOR BONE TISSUE ENGINEERING

BMSCs-laden mechanically reinforced bioactive sodium alginate composite hydrogel microspheres for minimally invasive bone repair

In Vitro Degradability, Bioactivity And Primary Cell Responses To Bone Cements Containing Mesoporous Magnesium-Calcium Silicate And Calcium Sulfate For Bone Regeneration

Developing a Novel Magnesium Calcium Phosphate/sodium Alginate Composite Cement with High Strength and Proper Self-Setting Time for Bone Repair

Novel Calcium Silicate/Calcium Phosphate Composites for Potential Applications As Injectable Bone Cements

A Composite of Cubic Calcium-Magnesium Sulfate and Bioglass for Bone Repair

Promotion of in Vivo Degradability, Vascularization and Osteogenesis of Calcium Sulfate-Based Bone Cements Containing Nanoporous Lithium Doping Magnesium Silicate

Effects of tricalcium silicate/sodium alginate/calcium sulfate hemihydrate composite cements on osteogenic performances in vitro and in vivo

Degradability and Osteogenesis of Mesoporous Magnesium Silicate Modified Calcium Sulphate Bone Cement

Osteogenic Differentiation and Immune Response of Human Bone-Marrow-derived Mesenchymal Stem Cells on Injectable Calcium-Silicate-based Bone Grafts.

Microencapsulated Rbmmscs/calcium Phosphate Cement for Bone Formation in Vivo.

Effect of Bone Morphogenic Protein-2-Loaded Mesoporous Strontium Substitution Calcium Silicate/Recycled Fish Gelatin 3D Cell-Laden Scaffold for Bone Tissue Engineering

Bioactive calcium sulfate/magnesium phosphate cement for bone substitute applications

Design and Manufacture of Bone Cements Based on Calcium Sulfate Hemihydrate and Mg, Sr-Doped Bioactive Glass

An Injectable In Situ Forming Collagen/Alginate/CaSO4 Composite Hydrogel for Tissue Engineering Applications: Optimization, Characterization and In Vitro Assessments

Design of novel organic-inorganic composite bone cements with high compressive strength, in vitro bioactivity and cytocompatibility.

A Bioactive Degradable Composite Bone Cement Based on Calcium Sulfate and Magnesium Polyphosphate

Novel Injectable Calcium Phosphate/chitosan Composites for Bone Substitute Materials